# SmartWatch ECG Evaluation Trial I

> **NCT05942274** · NA · WITHDRAWN · sponsor: **University of Oklahoma**

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DIAGNOSTIC_TEST:** We propose to validate these smartwatch ECG functions to support FDA submissions

## Key facts

- **NCT ID:** NCT05942274
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-12
- **Primary completion:** 2024-03
- **Final completion:** 2024-04-18
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The manufacturer who was to provide the study devices decided not to do so.
- **Last updated:** 2024-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05942274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05942274, "SmartWatch ECG Evaluation Trial I". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05942274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*